Bill Baumel - Profile and Investment Details

Investor Profile

Bill Baumel is a Venture Capital, Private Equity Firm, Entrepreneurship Program based in Columbus, Ohio, United States with a diverse investment portfolio that includes companies such as Stirling Ultracold, Enable Injections, DOmedia, Eccrine Systems, Complion, Immuta, EmployStream, S4 Medical, ConnXus, Spirosure, Mezu, Genetesis, RXQ Compounding, DAtAnchor, eFuse, Aware, ScriptDrop. Over time, Bill Baumel has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bill Baumel is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Delivery Service, Cybersecurity, Women Founded, Medical Testing, Enterprise Software, Recruiting, Women Led, Employment, News Media, Artificial Intelligence (AI), Analytics, Social Entrepreneurship, Medical Device, Software, Healthcare, Web Apps, Mobile Apps, Productivity Software, Management Consulting, Health Diagnostics, Internet, Medical, SaaS, Big Data, Esports, Video Games, Media and Entertainment, Personal Health, Emergency Medicine, Black / African American Founded, Compliance, Service Industry, Risk Management, Business Intelligence, Security may find it worthwhile to explore potential connections with Bill Baumel, as their portfolio suggests a familiarity and interest in this area.

Understanding Bill Baumel’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.